A multicohort, biomarker-driven phase 2 trial of personalized total neoadjuvant therapy with targeted agents for high-risk rectal cancer (The TRAINER study)
Tao Ma, Jingyi Liu, Sen Zhang, Abe Fingerhut et autres
cn, at, hk, th (code pays fourni par la source)
0 citations
Signal Transduction and Targeted Therapy